Related Experiment Video
Updated: May 29, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Inequalities in Developing Cirrhosis Complications Over Time: A Cohort Study
George Cholankeril1,2, Thomas Taylor1,3, Jennifer R Kramer1,3
1Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Half of patients with cirrhosis progressed, while many remained stable. Younger patients and alcohol-related cirrhosis showed faster progression, emphasizing early interventions for better outcomes.
Area of Science:
- Hepatology
- Clinical Epidemiology
- Chronic Liver Disease Research
Background:
- Current understanding of cirrhosis progression relies on outdated data.
- This study investigates contemporary cirrhosis progression patterns in a large veteran cohort.
Purpose of the Study:
- To analyze cirrhosis progression dynamics in a modern patient population.
- To identify factors influencing the transition from compensated cirrhosis to various complications or death.
Main Methods:
- Retrospective cohort study of 24,679 adult patients with compensated cirrhosis.
- Utilized a semi-Markov multistate model with 7 states and 15 transitions.
- Incorporated age and etiology (hepatitis C virus, alcohol, MASLD) as time-varying factors.
Main Results:
- Nearly 50% of patients progressed to a complication, most commonly ascites (30.3%).
- 12.9% transitioned directly to death from non-liver causes; 26% remained compensated.
- The 2-year mortality risk (13.5%) surpassed the risk of any complication.
Conclusions:
- Cirrhosis progression is heterogeneous, with significant portions progressing, remaining stable, or dying directly.
- Age and etiology (e.g., alcohol, active HCV) are key determinants of progression and outcomes.
- Interventions targeting the pre-complication phase are crucial for improving patient outcomes.
More Related Videos
08:56Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
04:00Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
Published on: November 15, 2024
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Esophageal Varices-I: Introduction
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...